checkAd

     291  0 Kommentare Catabasis Pharmaceuticals to Report Second Quarter 2019 Financial Results and Recent Corporate Developments on Thursday, August 8th

    Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, will report second quarter 2019 financial results before the Nasdaq Global Market open on Thursday, August 8, 2019. Jill C. Milne, Ph.D., Chief Executive Officer, will host a conference call and webcast at 8:30am ET to provide an update on corporate developments and to discuss second quarter financial results.

    Conference Call Dial-In Information:

    Participant Toll-Free Dial-In Number:

    (877) 388-2733

    Participant International Dial-In Number:

    (541) 797-2984

    Pass Code:

    4740699

    Please specify to the operator that you would like to join the “Catabasis Second Quarter 2019 Results Call.”

    Interested parties may access a live audio webcast of the conference call via the investors section of the Catabasis website, www.catabasis.com. Please connect to the Catabasis website several minutes prior to the start of the webcast to ensure adequate time for any software download that may be necessary. The webcast will be archived for 90 days.

    About Catabasis
    At Catabasis Pharmaceuticals, our mission is to bring hope and life-changing therapies to patients and their families. Our lead program is edasalonexent, an NF-kB inhibitor in development for the treatment of Duchenne muscular dystrophy. The global Phase 3 PolarisDMD trial is currently enrolling boys affected by Duchenne. For more information on edasalonexent and our Phase 3 trial, please visit www.catabasis.com.



    Business Wire (engl.)
    0 Follower
    Autor folgen

    Catabasis Pharmaceuticals to Report Second Quarter 2019 Financial Results and Recent Corporate Developments on Thursday, August 8th Catabasis Pharmaceuticals, Inc. (NASDAQ:CATB), a clinical-stage biopharmaceutical company, will report second quarter 2019 financial results before the Nasdaq Global Market open on Thursday, August 8, 2019. Jill C. Milne, Ph.D., Chief Executive …